GR78040B - - Google Patents

Info

Publication number
GR78040B
GR78040B GR69321A GR820169321A GR78040B GR 78040 B GR78040 B GR 78040B GR 69321 A GR69321 A GR 69321A GR 820169321 A GR820169321 A GR 820169321A GR 78040 B GR78040 B GR 78040B
Authority
GR
Greece
Prior art keywords
new
composition
effective
treatment
bismuth
Prior art date
Application number
GR69321A
Other languages
Greek (el)
English (en)
Inventor
Petrus J H Bos
Dirk Ju C Engel
Hayo De Jonge
Original Assignee
Brocades Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brocades Pharma Bv filed Critical Brocades Pharma Bv
Publication of GR78040B publication Critical patent/GR78040B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/29Antimony or bismuth compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Supply, Installation And Extraction Of Printed Sheets Or Plates (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Cereal-Derived Products (AREA)
GR69321A 1981-09-22 1982-09-20 GR78040B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30437281A 1981-09-22 1981-09-22

Publications (1)

Publication Number Publication Date
GR78040B true GR78040B (enExample) 1984-09-26

Family

ID=23176246

Family Applications (1)

Application Number Title Priority Date Filing Date
GR69321A GR78040B (enExample) 1981-09-22 1982-09-20

Country Status (17)

Country Link
EP (1) EP0075992B1 (enExample)
JP (1) JPS58501590A (enExample)
AT (1) ATE15598T1 (enExample)
AU (1) AU563692B2 (enExample)
CA (1) CA1198367A (enExample)
DE (1) DE3266403D1 (enExample)
DK (1) DK160533C (enExample)
ES (1) ES8400240A1 (enExample)
FI (1) FI77156C (enExample)
GR (1) GR78040B (enExample)
HU (1) HU193524B (enExample)
IE (1) IE53958B1 (enExample)
NZ (1) NZ201911A (enExample)
PH (1) PH20649A (enExample)
PT (1) PT75550B (enExample)
WO (1) WO1983001001A1 (enExample)
ZA (1) ZA826893B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
EP0206625B1 (en) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Compositions for the treatment of gastrointestinal disorders
EP0206627B1 (en) * 1985-06-13 1992-08-12 Barry James Dr. Marshall Methods for the treatment of gastrointestinal disorders
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
AU5019196A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
ES2267108T3 (es) * 1995-08-24 2007-03-01 Josman Laboratories, Inc. Composiciones que contienen bismuto en formas de dosificacion topicas.
RU2189942C1 (ru) * 2001-06-26 2002-09-27 Институт химии твердого тела и механохимии СО РАН Способ получения висмут-калий-аммоний цитрата
RU2416571C1 (ru) * 2010-02-15 2011-04-20 Учреждение Российской академии наук Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмута цитрата
RU2496719C1 (ru) * 2012-02-17 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут калий цитрата
RU2570610C1 (ru) * 2014-10-02 2015-12-10 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут аммоний цитрата
RU2675869C1 (ru) * 2018-02-05 2018-12-25 Общество с ограниченной ответственностью "Брайт Вэй" Способ получения висмут-калий-аммоний цитрата

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions

Also Published As

Publication number Publication date
DE3266403D1 (en) 1985-10-24
FI831815A0 (fi) 1983-05-20
EP0075992A1 (en) 1983-04-06
DK208083A (da) 1983-05-10
JPS58501590A (ja) 1983-09-22
ZA826893B (en) 1983-07-27
HU193524B (en) 1987-10-28
IE822299L (en) 1983-03-22
IE53958B1 (en) 1989-04-26
NZ201911A (en) 1985-10-11
DK208083D0 (da) 1983-05-10
FI77156B (fi) 1988-10-31
EP0075992B1 (en) 1985-09-18
ATE15598T1 (de) 1985-10-15
JPH0330573B2 (enExample) 1991-04-30
WO1983001001A1 (en) 1983-03-31
CA1198367A (en) 1985-12-24
DK160533C (da) 1991-09-09
PT75550B (en) 1984-12-12
FI77156C (fi) 1989-02-10
DK160533B (da) 1991-03-25
FI831815L (fi) 1983-05-20
AU8950382A (en) 1983-04-08
ES515848A0 (es) 1983-10-16
PT75550A (en) 1982-10-01
PH20649A (en) 1987-03-16
AU563692B2 (en) 1987-07-16
ES8400240A1 (es) 1983-10-16

Similar Documents

Publication Publication Date Title
GR78040B (enExample)
DE3370799D1 (en) A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
GB2020266A (en) Process for the treatment of water by cation exchange
DE3564431D1 (en) Process for the preparation of storage-stable benzothiazole-sulfenamides
DE3264314D1 (en) Fungicidal agent
YU43052B (en) Process for the purification of gallium water solutions
JPS532383A (en) Treatment of sludge contained oil
DE3264143D1 (en) Process for the elimination of molybdenum from aqueous solutions of manganese salts
JPS5520827A (en) Water valve controller
IL55565A (en) Quantitative determination of tsh in aqueous solutions by radioimmunoassay
PT74274A (fr) Procede de preparation de l'amino-4-butyramide
JPS54121296A (en) Method of removing arsenic from as contained concentrated ferrous sulfate aqueous solution
DE3264330D1 (en) Process for the preparation of cycloalkenon derivatives
NZ197436A (en) Preparing aqueous solutions of calcium nitrite
JPS5211194A (en) Method for controlling basicity of basic aluminum sulfate solution
JPS53127406A (en) Preparation of glycols
JPS5274587A (en) Regeneration of cation exchange resin
ZA82623B (en) Sparingly water-soluble salts of penicillanic acid 1,1-dioxide
IE781895L (en) Purification of zinc sulphate solutions.
NZ196106A (en) Cystalline gluconate salt of m-amsa